An approach for the preparation of tetrandrine sustained release calcium alginate gel beads was described. In vitro the release of tetrandrine from sustained release dosage forms went on a time of 12 hours whichˆtted non-Fickian diŠu-sion with matrix erosion signiˆcantly. In vivo the plasma concentration of tetrandrine extended preparation given in dogs reached C max 2.67±0.69 mg/ml approximately at 5.67±0.58 h after oral administration. The AUC 0→24 and AUC 0→∞ were 24.64±6.77 mg･h/l and 29.75±5.30 mg･h/l, respectively. The elimination half-time was 9.6±2.40 h. While a favorable correlativity existed between in vitro and in vivo with a correlative coe‹cient of 0.9798 through linear regression. An investigation on the quantitative relationship between in vitro release and in vivo absorption is a highly necessary work guided for manufacture, optimization and in vivo evaluation of sustained release dosage by means of in vitro release or dissolution tests.
INTRODUCTION
Tetrandrine (TET) is an important bisbenzylisoquinoline alkaloid isolated from the bulbous root of Stephania tetrandra S. Moore of the Menispermaceae family known as``hanfangji'', which is one of Chinese herbal medicine traditionally used for the treatment of edema, rheumatic disorders, and in‰am-matory diseases. TET, its mainly active component, is qualiˆed with obviously pharmacological action including anti-in‰ammatory, anti-allergic, antioxidant, anti-hepaticˆbrosis as well as being eŠective in the treatment of arrhythmia, hypertension, silicosis, and so on. 1) Besides plenty of pharmacological eŠects mentioned above together with some pharmacokinetics and analytical methods of TET raw material reported, 2 4) quite a few pharmacokinetic researches of TET oral sustained release preparation were carried on. In this study we primarily investigated the in vitro drug release from TET sustained release calcium alginate gel beads and its absorption in vivo, and consequently looked for the correlativity for both. The establishment of a relationship between in vitro and in vivo is the main purpose, which is instructional and convenient for further clinical research towards sustained or controlled release preparations.
MATERIALS AND METHODS

Materials
TET and theophylline standard were obtained from The National Institute for the Control of Pharmaceutical and Biological Products (Beijing, China). TET raw material (purity＞98％) was purchased from Xi'an Huike Bio-Tech Co. Ltd. (Xi'an, China). Acetonitrile (HPLC grade) was purchased from Fisher Scientiˆc (Pittsburgh, USA) and other chemicals and solvents were all of analytical-reagent grade.
Instrumentation The HPLC systems (HITACHI, Japan) were equipped with L-7110 HPLC pump and L-7420 ultraviolet detector coupled with a HW-2000 analytical workstation (Nanjing Qianpu Software Co. Ltd., China).
HPLC Conditions
Liquid chromatographic analysis was performed on a Hypersil ODS C 18 analytical column (4.6 mm×250 mm i.d., 5 mm, Elite Analytical Instruments Co. Ltd., Dalian China) with a guard column YWG C 18 (30 mm×4.6 mm) at 25°C. The mobile phase was consisited of acetonitrile: pH3.6 acetate buŠer solution (10: 90, v/v) at a ‰ow rate of 1.0 ml/min. Under the conditions TET and theophylline (used as internal standard) detected at 270nm were eluted at approximately 4.78 and 8.86 min without signiˆcant interference in blank dog plas- Sample Preparation A 1.0 ml aliquot of each plasma sample was transferred to 10 ml centrifugal tube with aˆxed amount of internal standard (100 ml); then 4.0 ml dichlormethane was added to the tube and vortexed for 1 min. After centrifugation (10 min at 6000 r/min) the supernatant was transferred to a fresh tube and evaporated to dryness at 45°C in nitrogen atmosphere. Theˆnal residue was dissolved in 100 ml mobile phase with vortex-mixing for 30 s. An aliquot of 20 ml was subjected to the HPLC.
Preparation of TET Sustained Release Calcium Alginate Gel Beads TET sustained release calcium alginate gel beads were prepared as described previously. 6) The gel beads loading TET were prepared by dropping 2.5％ sodium alginate into 0.3 mol/ l CaCl 2 at the rate of 30 drops/min. After a curing period of 24 h in CaCl 2 solution the beads werê ltered and washed with distilled water, then dried at 40°C for 24 h. Because of the solubility of TET sensible to pH value, TET calcium alginate gel beads were coated by ‰uidized bed technique to extend drug release. The coating formulation was composed of Eudragit RS 30D/Eudragit RL 30D (5: 1), 20％ triethyl citrate (TEC) and 35％ talcum. Sustainedrelease could be achieved as the coating weight increasing up to 45％.
Release of TET Sustained Release Calcium Alginate Gel Beads In Vitro
As the swelling of calcium alginate gel beads and solubility of TET was in‰uenced by pH value, 0.1 mol/l HCl solution was selected as the release medium and replaced by pH6.8 PBS 2 h later to simulate the human gastrointestinal tract. 7) The release of TET was studied using CP 2005 XC dissolution test apparatus employing a basket method. The solvent (900 ml) was maintained at 37 ±0.5°C, and continuously stirred at 100±1 r/min. Sample aliquots were collected at prescheduled time and replaced with an equivalent volume of fresh solvent. Drug release was analyzed and calculated by ultraviolet spectrophotometer at 264 nm as reported previously. 5) Pharmacokinetics of TET Sustained Release Calcium Alginate Gel Beads In Vivo Healthy dogs were purchased from The General Hospital of Shenyang Military Region weighing 20±2.5 kg. After an overnight fast with free access to water, the dogs were orally given a single dose of TET sustained release calcium alginate gel beads within six capsules (100 mg/capsule) or commercial TET tablets (40 mg/ tablet) as reference formulation (RF). The dogs were further fasted for 2 h following administration. About 2 ml blood sample were collected from small saphena to heparinized tubes at predetermined intervals. The blood sample were centrifuged at 3000 r/ min for 5 min at room temperature; then the separated plasma was stored at -20°C until analysis within 1 months.
RESULTS AND DISCUSSIONS
In Vitro Studies
Proˆle of the mean cumulative TET from the sustained release gel beads was illustrated in Fig. 1 . Three batches of products were all able to delay drug release for 12 h. During theˆrst two hours in 0.1 mol/l HCl drug release was less than 25％ and in the end nearly all of TET released, which was supposed to be a precondition for preferable bioavailability in vivo. From the release proˆle it was observed that the percentage of released drug increased rapidly after 4 h, which was owing to the swelling property of calcium alginate susceptible to the environment of pH. During theˆrst two hours in 0.1 mol/l HCl solution, calcium alginate gel beads did not happen to swell or erode and still keep intact matrix, as well as the outer Eudragitˆlm-coating. Two hours later the medium was displaced by pH6.8 PBS, in which cross-linking calcium alginate gel converted to soluble sodium alginate gel by ion-exchange. 8) As a result the gel beads appeared to swell and showed further erosion, which led to the gradual break of the Eudragitˆlm-coating. So the released drug increased rapidly after 4 h compared with before.
Furthermore, the information obtained in the mathematic model of the cumulative release percent in vitro should be an important aid for formulators. Drug release dynamics is the key to study sustained and controlled release dosage forms, and mathematic models adopted is mainly the investigative method, such as zero-order/ˆrst-order kinetic equation, Higuchi equation, Hixson-Crowell equation and Ritger-Peppas equation. 9) Based on theˆtted linear regression equation achieved from cumulative release percent versus time (Table 1) , it is concluded that TET sustained release gel beads should meet nonFickian diŠusion, that is the co-operation of drug diŠusion and hydrophilic matrix erosion. As observed in fact, the matrix of gel beads were absolute erosion eventually. Combined with the goodˆtted linear regression line of Hixson-Crowell equation, the matrix erosion mechanism should play an important role during the course of drug release.
In Vivo Studies C max and T max were the actually determined data, while AUC was calculated by trapezoidal method. Other pharmacokinetic parameters were obtained by 3P97 pharmacokinetics software and summarized in Table 2 . The mean concentration versus time proˆles are shown in Fig. 2 . There obviously existed slow absorption and elimination for TET sustained release calcium alginate gel beads contrasted with ordinary tablets (see Tables 2  and 3 ). Following oral administration of 30 mg/kg TET, plasma levels of TET sustained release gel beads reached C max 2.67±0.69 mg/ml about 5.67±0.58 h after taking medicine. The AUC 0→24 and AUC 0→∞ TET sustained release gel beads werê tted one-compartment model based on residual sum of squares, Akaike's information criterion (AIC) and r 2 obtained from 3P97 software. Consequently, absorption percents F(t) were calculated by WagnerNelson equation. 10) Correlativity in vitro and in vivo was investigated using the percent absorbed data versus percent released for TET sustained release gel beads ( Table 4 ). The correlative coe‹cient of regress equation f(t)＝1.276F(t)＋15.683 was 0.9780. There existed a favorable linear regression relationship (Fig.  3) .
CONCLUSIONS
The studies of release testing in medium and pharmacokinetics in dogs indicated that the desired purpose of sustained release was achieved. Plasma concentration maintained relatively constant for more than 12 hours. The release of sustained released gel beads in vitro was correlative with in vivo absorption fraction well.
The objective of an in vitro and in vivo correlation was the application of release test to screen formulation with ideal absorption after administration partly instead of bioequivalence test.
In conclusion each drug product should be tested individually with the release test that best correlates to in vivo bioavailability. Since the release tests do serve as an essential component in the overall quality control of preparation manufacture and guidelines for in vivo absorption.
